Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113 individuals from the UK Prospective Diabetes Study. In a combined meta-analysis, we identified a SNP, rs11212617, associated with treatment success (n = 3,920, P = 2.9 × 10(-9), odds ratio = 1.35, 95% CI 1.22-...Expand abstract
- Publisher copy:
- Copyright date:
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
If you are the owner of this record, you can report an update to it here: Report update to this record